Mr Colin BrightMr Colin Bright

Colin joined Argenta in August 2000. He has over 30 years of drug discovery experience within big pharma, covering a wide range of projects including parasitology, inflammation and cardiovascular in vivo disease models, and also of in vitro screening using a wide variety of biochemical and cellular technologies.

In recent years, he has built and operated the impressive array of Argenta capabilities of eADMET technologies, using his combination of ADMET experience and automation skills.

 

close windowprint window